• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C6-吡啶鎓神经酰胺使SCC17B人头颈鳞状细胞癌细胞对光动力疗法敏感。

C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy.

作者信息

Boppana Nithin B, Stochaj Ursula, Kodiha Mohamed, Bielawska Alicja, Bielawski Jacek, Pierce Jason S, Korbelik Mladen, Separovic Duska

机构信息

Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave., Detroit, MI 48201, USA.

Department of Physiology, McGill University, 3655 Promenade Sir William Osler, Montreal, QC H3G 1YC, Canada.

出版信息

J Photochem Photobiol B. 2015 Feb;143:163-8. doi: 10.1016/j.jphotobiol.2015.01.001. Epub 2015 Jan 10.

DOI:10.1016/j.jphotobiol.2015.01.001
PMID:25635908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4662378/
Abstract

Combining photodynamic therapy (PDT) with another anticancer treatment modality is an important strategy for improved efficacy. PDT with Pc4, a silicon phthalocyanine photosensitizer, was combined with C6-pyridinium ceramide (LCL29) to determine their potential to promote death of SCC17B human head and neck squamous cell carcinoma cells. PDT+LCL29-induced enhanced cell death was inhibited by zVAD-fmk, a pan-caspase inhibitor, and fumonisin B1 (FB), a ceramide synthase inhibitor. Quantitative confocal microscopy showed that combining PDT with LCL29 enhanced FB-sensitive ceramide accumulation in the mitochondria. Furthermore, PDT+LCL29 induced enhanced FB-sensitive redistribution of cytochrome c and caspase-3 activation. Overall, the data indicate that PDT+LCL29 enhanced cell death via FB-sensitive, mitochondrial ceramide accumulation and apoptosis.

摘要

将光动力疗法(PDT)与另一种抗癌治疗方式相结合是提高疗效的重要策略。将含有硅酞菁光敏剂Pc4的光动力疗法与C6-吡啶鎓神经酰胺(LCL29)相结合,以确定它们促进SCC17B人头颈部鳞状细胞癌细胞死亡的潜力。泛半胱天冬酶抑制剂zVAD-fmk和神经酰胺合酶抑制剂伏马菌素B1(FB)抑制了PDT+LCL29诱导的增强的细胞死亡。定量共聚焦显微镜显示,将PDT与LCL29相结合可增强线粒体中对FB敏感的神经酰胺积累。此外,PDT+LCL29诱导了细胞色素c对FB敏感的重新分布和半胱天冬酶-3的激活增强。总体而言,数据表明PDT+LCL29通过对FB敏感的线粒体神经酰胺积累和细胞凋亡增强了细胞死亡。

相似文献

1
C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy.C6-吡啶鎓神经酰胺使SCC17B人头颈鳞状细胞癌细胞对光动力疗法敏感。
J Photochem Photobiol B. 2015 Feb;143:163-8. doi: 10.1016/j.jphotobiol.2015.01.001. Epub 2015 Jan 10.
2
Ceramide synthase inhibitor fumonisin B1 inhibits apoptotic cell death in SCC17B human head and neck squamous carcinoma cells after Pc4 photosensitization.神经酰胺合酶抑制剂伏马菌素B1可抑制Pc4光致敏后SCC17B人头颈鳞状癌细胞的凋亡性细胞死亡。
Photochem Photobiol Sci. 2014 Nov;13(11):1621-7. doi: 10.1039/c4pp00292j.
3
Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.伏马菌素B1抑制Foscan光动力疗法联合C6-吡啶鎓神经酰胺或维甲酸后内质网应激相关的细胞凋亡。
Anticancer Res. 2017 Feb;37(2):455-463. doi: 10.21873/anticanres.11337.
4
Enhanced killing of SCC17B human head and neck squamous cell carcinoma cells after photodynamic therapy plus fenretinide via the de novo sphingolipid biosynthesis pathway and apoptosis.光动力疗法联合维甲酸通过从头鞘脂生物合成途径和凋亡增强对SCC17B人头颈部鳞状细胞癌细胞的杀伤作用。
Int J Oncol. 2015 May;46(5):2003-10. doi: 10.3892/ijo.2015.2909. Epub 2015 Feb 26.
5
Amplification of cancer cell apoptosis in photodynamic therapy-treated tumors by adjuvant ceramide analog LCL29.辅助性神经酰胺类似物LCL29增强光动力疗法治疗肿瘤中癌细胞的凋亡
Lasers Surg Med. 2011 Sep;43(7):614-20. doi: 10.1002/lsm.21068.
6
Fumonisin B1 does not prevent apoptosis in A431 human epidermoid carcinoma cells after photosensitization with a silicon phthalocyanine.伏马菌素B1不能阻止硅酞菁光致敏后A431人表皮癌细胞的凋亡。
J Photochem Photobiol B. 2000 Sep;57(2-3):132-41. doi: 10.1016/s1011-1344(00)00088-9.
7
Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.光动力疗法联合 dasatinib 治疗可增强 SCCVII 鳞状细胞癌细胞的杀伤作用,其与 caspase-3 活性增强和神经酰胺合酶 1 上调有关。
Int J Oncol. 2013 Dec;43(6):2064-72. doi: 10.3892/ijo.2013.2132. Epub 2013 Oct 9.
8
Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.Foscan 光动力疗法联合神经酰胺类似物 LCL29 增强肿瘤治愈率。鳞癌细胞作为治疗反应生物标志物的证据表明鞘脂类物质具有应用前景。
Int J Oncol. 2011 Feb;38(2):521-7. doi: 10.3892/ijo.2010.863. Epub 2010 Dec 6.
9
FADD null mouse embryonic fibroblasts undergo apoptosis after photosensitization with the silicon phthalocyanine Pc 4.FADD基因敲除的小鼠胚胎成纤维细胞在用硅酞菁Pc 4进行光致敏后会发生凋亡。
Arch Biochem Biophys. 2001 Jan 1;385(1):194-202. doi: 10.1006/abbi.2000.2143.
10
Monitoring ceramide and sphingosine-1-phosphate levels in cancer cells and macrophages from tumours treated by photodynamic therapy.监测光动力疗法治疗的肿瘤中癌细胞和巨噬细胞内神经酰胺和1-磷酸鞘氨醇的水平。
Photochem Photobiol Sci. 2012 May;11(5):779-84. doi: 10.1039/c2pp05384e. Epub 2012 Feb 22.

引用本文的文献

1
Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer.鞘脂类在炎症性肠病和结直肠癌中的治疗潜力
Cancers (Basel). 2024 Feb 15;16(4):789. doi: 10.3390/cancers16040789.
2
Sphingolipids in mitochondria-from function to disease.线粒体中的鞘脂——从功能到疾病
Front Cell Dev Biol. 2023 Nov 21;11:1302472. doi: 10.3389/fcell.2023.1302472. eCollection 2023.
3
Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma.

本文引用的文献

1
Ceramide synthase inhibitor fumonisin B1 inhibits apoptotic cell death in SCC17B human head and neck squamous carcinoma cells after Pc4 photosensitization.神经酰胺合酶抑制剂伏马菌素B1可抑制Pc4光致敏后SCC17B人头颈鳞状癌细胞的凋亡性细胞死亡。
Photochem Photobiol Sci. 2014 Nov;13(11):1621-7. doi: 10.1039/c4pp00292j.
2
Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.光动力疗法联合 dasatinib 治疗可增强 SCCVII 鳞状细胞癌细胞的杀伤作用,其与 caspase-3 活性增强和神经酰胺合酶 1 上调有关。
Int J Oncol. 2013 Dec;43(6):2064-72. doi: 10.3892/ijo.2013.2132. Epub 2013 Oct 9.
3
神经酰胺和鞘氨醇代谢酶抑制剂作为头颈部鳞状细胞癌放疗和化疗的增敏剂
Cancers (Basel). 2020 Jul 26;12(8):2062. doi: 10.3390/cancers12082062.
4
Antineoplastic Agents Targeting Sphingolipid Pathways.靶向鞘脂途径的抗肿瘤药物。
Front Oncol. 2020 May 22;10:833. doi: 10.3389/fonc.2020.00833. eCollection 2020.
5
Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.伏马菌素B1抑制Foscan光动力疗法联合C6-吡啶鎓神经酰胺或维甲酸后内质网应激相关的细胞凋亡。
Anticancer Res. 2017 Feb;37(2):455-463. doi: 10.21873/anticanres.11337.
6
Enhanced apoptotic cancer cell killing after Foscan photodynamic therapy combined with fenretinide via de novo sphingolipid biosynthesis pathway.Foscan光动力疗法联合阿维A酸通过从头鞘脂生物合成途径增强对凋亡癌细胞的杀伤作用。
J Photochem Photobiol B. 2016 Jun;159:191-5. doi: 10.1016/j.jphotobiol.2016.02.040. Epub 2016 Mar 16.
Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.初步临床和药理学研究光动力疗法与硅酞菁光敏剂 pc 4 治疗原发性或转移性皮肤癌。
Front Oncol. 2011 Jun 30;1:14. doi: 10.3389/fonc.2011.00014. eCollection 2011.
4
Amplification of cancer cell apoptosis in photodynamic therapy-treated tumors by adjuvant ceramide analog LCL29.辅助性神经酰胺类似物LCL29增强光动力疗法治疗肿瘤中癌细胞的凋亡
Lasers Surg Med. 2011 Sep;43(7):614-20. doi: 10.1002/lsm.21068.
5
Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients.评估 90 例患者 157 个基底细胞癌经局部涂抹氨基酮戊酸光动力疗法治疗后的复发情况。
Acta Derm Venereol. 2012 Mar;92(2):144-7. doi: 10.2340/00015555-1198.
6
Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation.线粒体富含神经酰胺的巨域在照射后使 Bax 功能化。
PLoS One. 2011;6(6):e19783. doi: 10.1371/journal.pone.0019783. Epub 2011 Jun 13.
7
Many ceramides.许多神经酰胺。
J Biol Chem. 2011 Aug 12;286(32):27855-62. doi: 10.1074/jbc.R111.254359. Epub 2011 Jun 21.
8
C16-Ceramide Analog Combined with Pc 4 Photodynamic Therapy Evokes Enhanced Total Ceramide Accumulation, Promotion of DEVDase Activation in the Absence of Apoptosis, and Augmented Overall Cell Killing.C16-神经酰胺类似物与Pc 4光动力疗法联合使用可增强总神经酰胺积累,在无细胞凋亡情况下促进DEVD酶激活,并增强整体细胞杀伤作用。
J Lipids. 2011;2011:713867. doi: 10.1155/2011/713867. Epub 2010 Dec 14.
9
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.硅酞菁(Pc 4)光动力疗法是一种治疗皮肤肿瘤的安全方法:一项1期临床试验的结果
Lasers Surg Med. 2010 Dec;42(10):728-35. doi: 10.1002/lsm.20984.
10
Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.Foscan 光动力疗法联合神经酰胺类似物 LCL29 增强肿瘤治愈率。鳞癌细胞作为治疗反应生物标志物的证据表明鞘脂类物质具有应用前景。
Int J Oncol. 2011 Feb;38(2):521-7. doi: 10.3892/ijo.2010.863. Epub 2010 Dec 6.